InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (57 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
57
T+90 hit rate
40%
T+90 mean return
-14.4%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Borgeson Blake, Director. Director active across 1 company, notably Recursion Pharmaceuticals, INC.. Aggregated, 72 filings have been recorded. Breakdown: 0 buy · 57 sells. Total volume traded: €5.2m. History available since 1 July 2021. The latest transaction was disclosed on 7 July 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations72 total
40,000 shares@ US$3.9625Class A Common StockSEC:0001856094-26-000011:0
88,424 sharesClass A Common StockSEC:0001601830-26-000088:0
30,000 shares@ US$3.680.0051% mcap1.8% of flowClass A Common StockSEC:0001856094-26-000008:0
30,000 shares@ US$3.101.5% of flowClass A Common StockSEC:0001856094-26-000003:0
1,734 shares0Class A Common StockSEC:0001601830-25-000004:0
11,447 shares@ US$7.64021.6% of flowClass A Common StockSEC:0001601830-24-000205:0
11,447 shares@ US$6.72021.4% of flowClass A Common StockSEC:0001601830-24-000186:0
11,447 shares@ US$6.66781.4% of flowClass A Common StockSEC:0001601830-24-000179:0
2,026 shares0Class A Common StockSEC:0001601830-24-000174:0
11,447 shares@ US$6.21561.3% of flowClass A Common StockSEC:0001601830-24-000166:0
11,447 shares@ US$6.84311.4% of flowClass A Common StockSEC:0001601830-24-000160:0
11,447 shares@ US$6.26521.3% of flowClass A Common StockSEC:0001601830-24-000154:0
11,447 shares@ US$7.12261.4% of flowClass A Common StockSEC:0001601830-24-000129:0
11,447 shares@ US$6.82131.4% of flowClass A Common StockSEC:0001601830-24-000119:0
11,447 shares@ US$8.47741.7% of flowClass A Common StockSEC:0001601830-24-000104:0
11,447 shares@ US$7.3151.5% of flowClass A Common StockSEC:0001601830-24-000100:0
1,441 shares0Class A Common StockSEC:0001601830-24-000096:0
11,447 shares@ US$9.50522.0% of flowClass A Common StockSEC:0001601830-24-000094:0
11,447 shares@ US$8.45311.8% of flowClass A Common StockSEC:0001601830-24-000082:0
13,097 shares0Class A Common StockSEC:0001601830-24-000071:0
11,447 shares@ US$9.16771.9% of flowClass A Common StockSEC:0001601830-24-000067:0
20,054 shares@ US$10.11943.7% of flowClass A Common StockSEC:0001601830-24-000055:0
11,447 shares@ US$7.94651.7% of flowClass A Common StockSEC:0001601830-24-000046:0
11,447 shares@ US$7.66361.6% of flowClass A Common StockSEC:0001601830-24-000037:0
11,447 shares@ US$8.81821.8% of flowClass A Common StockSEC:0001601830-24-000027:0
25 of 72 declarations
About Borgeson Blake
Blake Borgeson serves as a Board Member at Recursion Pharmaceuticals, Inc. He is involved in the governance of the company, bringing his expertise in the pharmaceutical sector. Recursion Pharmaceuticals focuses on using artificial intelligence to discover new drugs. Mr. Borgeson's experience enables him to effectively contribute to the strategic discussions of the board.
